International reference: 6 US FDA recalls for this ingredient

Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles. (suppressant)

CGMP Deviations: Products are underdosed or have an incorrect dosage regime. (suppressant)

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii). (suppressant)

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality. (suppressant)

Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenes (suppressant)

Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups. (suppressant)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in Kenya.

Registered Kenya · PPB

LACOFF CODEIN

COUGH SUPPRESSANT

What it does

Cough medicine helps relieve coughing and soothe the throat.

Commonly used for: cough, dry cough, productive cough

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2009/22992/211
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
COUGH SUPPRESSANT
Strength
-
Pack size
BOTTLE
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Zain Pharma
Applicant / LTR
OSAKA GROUP LTD
Country of origin
LOCAL
Manufacturer location
Industriestraße 29, 64569 Nauheim, Germany

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:06:20 · updated 2026-08-03 04:06:35

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About cough

Cough medicine helps relieve coughing and soothe the throat.

What it treats

  • cough
  • dry cough
  • productive cough

How it works

It works by soothing the throat and reducing the urge to cough.

Who it's for

This medicine is suitable for anyone experiencing a cough.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About suppressant

A suppressant is a type of medicine that helps reduce or control specific symptoms, like coughing or excessive sneezing.

What it treats

  • cough
  • sneezing
  • other symptoms requiring suppression

How it works

Suppressants work by calming the body's response to irritation or overactivity, helping to alleviate unwanted symptoms.

Who it's for

Suppressants are for people experiencing symptoms like coughing or sneezing that need relief.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: cough

BNF-referenced

Cough refers to a reflex action to clear the airways of irritants, mucus, or foreign particles. It can be acute or chronic and is often associated with respiratory conditions such as infections, asthma, chronic obstructive pulmonary disease (COPD), or allergies. The management of cough may involve various pharmacological agents, including cough suppressants, expectorants, and mucolytics, depending on the underlying cause and symptomatology.

Indications

  • Acute cough
  • Chronic cough
  • Cough due to respiratory infections
  • Cough associated with asthma
  • Cough in chronic obstructive pulmonary disease (COPD)
  • Allergic cough
  • Post-nasal drip syndrome

Dosage

Children: Refer to the BNF for Children for specific dosing information based on the selected medication and age of the child.

Adults: Refer to the BNF for specific dosing information based on the selected medication and indication for cough.

Mechanism of action

Cough medications can act through various mechanisms depending on their classification. Cough suppressants (antitussives) like dextromethorphan inhibit the cough reflex in the brain, while expectorants like guaifenesin increase mucus secretion, making it easier to expel. Mucolytics, such as acetylcysteine, break down mucus structure, facilitating clearance from the airways.

Pharmacodynamics

The pharmacodynamics of cough medications vary widely. Antitussives primarily reduce the sensitivity of the cough reflex pathways in the central nervous system. Expectorants promote increased mucus production and reduce viscosity, aiding in expectoration. Mucolytics alter the physical properties of mucus, enhancing its clearance from the respiratory tract.

Pharmacokinetics

The pharmacokinetics of cough medications differ among classes. Antitussives are generally well-absorbed orally, with peak plasma concentrations occurring within 1-2 hours. They are metabolized in the liver and excreted primarily through urine. Expectorants and mucolytics also exhibit similar absorption profiles and are eliminated through renal pathways, although their metabolism may involve different enzymatic processes in the liver.

Pregnancy

Consult with a healthcare provider for advice regarding use during pregnancy.

Breast-feeding

Consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: suppressant

Suppressants are a broad class of medications that reduce the intensity of physiological functions or responses. They can act on various systems within the body, including the central nervous system, respiratory system, or other organ systems, depending on their specific type. Common examples include cough suppressants, which reduce coughing, and appetite suppressants, which decrease hunger. These agents are used to manage symptoms in various conditions, including respiratory disorders, anxiety, and obesity.

Indications

  • Cough relief
  • Anxiety management
  • Insomnia treatment
  • Weight loss
  • Pain relief

Dosage

Children: Refer to specific drug guidelines for exact dosing, as it varies by the type of suppressant used.

Adults: Refer to specific drug guidelines for exact dosing, as it varies by the type of suppressant used.

Mechanism of action

Suppressants may act through various mechanisms depending on their specific type. For example, central nervous system depressants may enhance the effects of neurotransmitters like gamma-aminobutyric acid (GABA) to induce sedation or relaxation. Respiratory suppressants may inhibit the cough reflex by acting on the cough center in the medulla oblongata. Appetite suppressants may work by influencing neurotransmitter levels, such as serotonin or norepinephrine, to promote feelings of satiety.

Pharmacodynamics

The pharmacodynamics of suppressants generally involve modulation of neurotransmitter activity, leading to reduced physiological responses. For central nervous system depressants, this may result in decreased neuronal excitability and calming effects. In the case of respiratory suppressants, the inhibition of the cough reflex provides symptomatic relief, while appetite suppressants may alter the signaling pathways involved in hunger and satiety, leading to reduced food intake.

Pharmacokinetics

The pharmacokinetics of suppressants can vary widely based on the specific agent. Generally, they are absorbed through the gastrointestinal tract and metabolized by the liver, with varying half-lives that influence dosing frequency. Many suppressants are excreted through the kidneys, and their onset of action can differ based on their formulation, whether immediate-release or extended-release. Factors such as age, weight, and liver function can affect the pharmacokinetics of these drugs.

Adverse effects

  • Drowsiness
  • Dizziness
  • Nausea
  • Vomiting
  • Constipation
  • Dry mouth
  • Confusion
  • Respiratory depression

Interactions

  • Alcohol, which may enhance sedative effects
  • Central nervous system depressants, such as benzodiazepines and opioids, which may increase risk of respiratory depression
  • Certain antidepressants and antipsychotics, which may increase drowsiness

Precautions

  • Use with caution in patients with a history of substance abuse
  • Monitor for signs of respiratory depression, especially in elderly or frail patients
  • Caution in patients with pre-existing respiratory conditions

Pregnancy

Safety during pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Use with caution as it may pass into breast milk and affect the nursing infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Oral tablets
  • Syrups
  • Inhalation solutions
  • Injectable solutions

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: cough

PubChem CID 11705476

Molecular formula: C28H39NO5

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.